Three Years After Oracle’s Cerner Acquisition: Where Are We Now?
KLAS just released its Oracle Health 2025 report, and the findings are telling:
🔹 Customer churn is accelerating — 57 acute-care customers have left Oracle Health since 2022, including 12 large health systems with over 1,000 beds.
🔹 Big promises, small follow-through — Nearly 50% of surveyed clients said they wouldn’t choose Oracle Health again today. Communication gaps and diminished vendor partnership are recurring themes.
🔹 A glimmer of progress: Clinical AI Agent — The rollout of Oracle’s Clinical AI Agent has captured attention, reducing clinician documentation burden and showing potential to meaningfully impact productivity and patient throughput.
🔹 Skepticism on the roadmap — While Oracle is betting big on AI-driven workflows and modernized infrastructure, customers remain uncertain about timelines, transparency, and delivery.
🔹 Market confidence is fragile — The migration to Oracle’s RevElate patient accounting platform and other enhancements is underway, but many health systems are taking a wait-and-see approach.
What It Means for Healthcare Leaders
For executives navigating shrinking margins, staffing shortages, and growing tech debt, Oracle’s performance will directly influence strategic planning:
Should you double down on Oracle’s roadmap, or hedge bets with alternative EHR strategies?
How will AI integration affect clinician productivity and operational costs?
What does customer attrition signal about vendor stability in the next 3–5 years?
Oracle has a vision, but KLAS’ findings make it clear: delivery, transparency, and trust will define their success — or failure — in the evolving EHR landscape.
Full KLAS Report: https://lnkd.in/gt3hEPT3
hashtag#HealthIT hashtag#EHR hashtag#OracleHealth hashtag#DigitalHealth hashtag#Leadership hashtag#HealthcareStrategy
